Modifi Bio is developing a novel oncology therapeutics platform that modifies tumor DNA to exploit DNA repair defects in cancer cells, while preserving healthy cells. This approach aims to enhance the efficacy of cancer treatments by directly targeting DNA with a new class of small molecules, circumventing traditional protein-targeted therapies.